You are here: All Products  > Ascletis Approved to Start China Trial of PD-L1 in HBV Patients

Ascletis Approved to Start China Trial of PD-L1 in HBV Patients

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products